Cargando…
Glucagon-like peptide-2 analogues for Crohn’s disease patients with short bowel syndrome and intestinal failure
Short bowel syndrome (SBS) with intestinal failure (IF) is a rare but severe complication of Crohn’s disease (CD), which is the most frequent benign condition that leads to SBS after repeated surgical resections, even in the era of biologics and small molecules. Glucagon-like peptide-2 analogues hav...
Autores principales: | Pizzoferrato, Marco, Puca, Pierluigi, Ennas, Sara, Cammarota, Giovanni, Guidi, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730438/ https://www.ncbi.nlm.nih.gov/pubmed/36504557 http://dx.doi.org/10.3748/wjg.v28.i44.6258 |
Ejemplares similares
-
Prognostic role of intestinal ultrasound in Crohn’s disease
por: Manzotti, Cristina, et al.
Publicado: (2023) -
Differentiating Crohn’s disease from intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2019) -
Chronic intestinal failure and short bowel syndrome in Crohn’s disease
por: Aksan, Aysegül, et al.
Publicado: (2021) -
Magnetic resonance enterography in Crohn’s disease: How we do it and common imaging findings
por: Mantarro, Annalisa, et al.
Publicado: (2017) -
Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome
por: Chatterjee, Sanjay, et al.
Publicado: (2016)